The Clinical, Epidemiological and Treatment Characteristics of Head and Neck Cancer Patients
NCT05319483 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2022-04-08
Summary
The aim of our study is to prospectively collect information regarding (1) the demographic, lifestyle-related and clinical characteristics of patients with head and neck cancer and (2) the waiting times to diagnosis and therapy, and the 1-, 3- and 5-year survival of patients. We plan to gain insight into the characteristics and pathways of head and neck cancer patients in Baranya County, which can in turn help to identify factors that lead to improved or worse disease outcomes. (Thus, these factors can subsequently eliminated or lessened to improve the outcome of head and neck cancer patients. )
Conditions
- Waiting Times, Patient Pathways, Effect of Lifestyle-related, Clinical and Demographic Parameters on Outcomes
Interventions
- OTHER
-
No intervention
No intervention.
Sponsors & Collaborators
-
University of Pecs
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-10-01
- Primary Completion
- 2024-10-01
- Completion
- 2029-10-01
Countries
- Hungary
Study Locations
More Related Trials
-
Induction Modified TPF Followed by Concurrent Chemoradiotherapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck
NCT05527782 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Head and Neck Carcinoma Clinical Research Platform for Molecular and Blood-based Biomarkers, Treatment and Outcome
NCT06380686 ·Status: RECRUITING
-
Acute and Long-term Impact of Cancer Treatment on Head and Neck Cancer Patients: FIT4TREATMENT
NCT04996147 ·Status: TERMINATED
-
Studying Survivorship Care Plans in Head and Neck Cancer
NCT03106090 ·Status: TERMINATED ·Phase: NA
-
Time to Treatment and Disease-free Survival of Patients With High-risk Head-neck Cutaneous Squamous Cell Carcinoma
NCT05845632 ·Status: UNKNOWN
-
Cell-free Tumor DNA in Head and Neck Cancer Patients
NCT03942380 ·Status: UNKNOWN ·Phase: NA
-
Reconstructive Surgery For Head And Neck Cancer Patients
NCT00578032 ·Status: COMPLETED
-
Observational Study on Biomarkers in Head and Neck Cancer (HNprädBio)
NCT02059668 ·Status: COMPLETED
-
Prognostic Immune Biomarkers in HNSCC
NCT05941676 ·Status: COMPLETED
-
Chemotherapy Followed by Surgery, Chemotherapy, and Radiation Therapy in Treating Patients With Locally Advanced Head And Neck Cancer
NCT00544414 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of the Implementation of Personalised Follow-up in Head and Neck Cancer
NCT06170203 ·Status: RECRUITING
-
Circulating Biomarkers in Oropharyngeal Cancers
NCT05904327 ·Status: ACTIVE_NOT_RECRUITING
-
Facilitators and Barriers to Dental Care in Head and Neck Cancer Patients
NCT06559384 ·Status: COMPLETED
-
Changes to Function and Quality of Life and Patient Experience for Patients Undergoing Treatments for Recurrent Oropharyngeal Cancer
NCT04952922 ·Status: COMPLETED
-
Nutritional Status of Head and Neck Cancer Patients
NCT07068711 ·Status: RECRUITING
-
Neck Surgery in Treating Patients With Early-Stage Oral Cancer
NCT00571883 ·Status: UNKNOWN ·Phase: NA
-
The Head and Neck Registry of the European Reference Network on Rare Adult Solid Cancers
NCT05483374 ·Status: RECRUITING
-
Phase III Open Label Study of MEDI 4736 With/Without Tremelimumab Versus Standard of Care (SOC) in Recurrent/Metastatic Head and Neck Cancer
NCT02551159 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of MEHD7945A in Combination With Cisplatin and 5-Fluorouracil (5-FU) or Paclitaxel and Carboplatin in Participants With Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (R/M SCCHN)
NCT01911598 ·Status: COMPLETED ·Phase: PHASE1
-
Induction Chemotherapy Followed by Cetuximab and Radiation Therapy for Head and Neck Cancer
NCT01467115 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of PD-1 Plus Chemotherapy in Poorly Differentiated Locally Advanced (LA) HNSCC
NCT06100497 ·Status: RECRUITING ·Phase: PHASE2
-
Evaluating the Efficacy and Safety of Pembrolizumab Plus Standard Chemotherapy in the Neoadjuvant Treatment of Local Advanced (LA) HNSCC
NCT06102395 ·Status: RECRUITING ·Phase: PHASE3
-
2 Phase Use Of Educational Materials In Head And Neck Cancer Center
NCT02204631 ·Status: COMPLETED ·Phase: NA
-
Nasopharyngeal Carcinoma Post IMRT
NCT02597426 ·Status: ACTIVE_NOT_RECRUITING
-
Tolerability and Efficacy of UV1 Vaccine in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Planned for First-line Treatment With Pembrolizumab
NCT05075122 ·Status: UNKNOWN ·Phase: PHASE2